Gene · 1237
Papers2,300
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 2,300
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Downregulation of T-cell cytotoxic marker IL18R1 promotes cancer proliferation and migration and is associated with dismal prognosis and immunity in lung squamous cell carcinoma. | Front Immunol | 2022 | 36544782 | PubTator, text mining | PubMed |
| ANK2 as a novel predictive biomarker for immune checkpoint inhibitors and its correlation with antitumor immunity in lung adenocarcinoma. | BMC Pulm Med | 2022 | 36539782 | PubTator, text mining | PubMed |
| LFSC: A linear fast semi-supervised clustering algorithm that integrates reference-bulk and single-cell transcriptomes. | Front Genet | 2022 | 36531230 | PubTator, text mining | PubMed |
| Insights into prognosis and immune infiltration of cuproptosis-related genes in breast cancer. | Front Immunol | 2022 | 36518756 | PubTator, text mining | PubMed |
| Genetic Heterogeneity, Tumor Microenvironment and Immunotherapy in Triple-Negative Breast Cancer. | Int J Mol Sci | 2022 | 36499265 | PubTator, text mining | PubMed |
| Extracellular Vesicles and Their Roles in the Tumor Immune Microenvironment. | J Clin Med | 2022 | 36498469 | PubTator, text mining | PubMed |
| Single-cell profiling of healthy human kidney reveals features of sex-based transcriptional programs and tissue-specific immunity. | Nat Commun | 2022 | 36496458 | PubTator, text mining | PubMed |
| CCL22 and CCL26 are potential biomarkers for predicting distant metastasis in thyroid carcinoma. | J Int Med Res | 2022 | 36495170 | PubTator, text mining | PubMed |
| Human gut microbiota-reactive DP8α regulatory T cells, signature and related emerging functions. | Front Immunol | 2022 | 36479125 | PubTator, text mining | PubMed |
| SPI1 is a prognostic biomarker of immune infiltration and immunotherapy efficacy in clear cell renal cell carcinoma. | Discov Oncol | 2022 | 36477668 | PubTator, text mining | PubMed |
| Comprehensive analysis of prognostic value, relationship to cell cycle, immune infiltration and m6A modification of ZSCAN20 in hepatocellular carcinoma. | Aging (Albany NY) | 2022 | 36462500 | PubTator, text mining | PubMed |
| ADGRD1 as a Potential Prognostic and Immunological Biomarker in Non-Small-Cell Lung Cancer. | Biomed Res Int | 2022 | 36457341 | PubTator, text mining | PubMed |
| Pan-cancer landscape of AID-related mutations, composite mutations, and their potential role in the ICI response. | NPJ Precis Oncol | 2022 | 36456685 | PubTator, text mining | PubMed |
| Minichromosome maintenance gene family: potential therapeutic targets and prognostic biomarkers for lung squamous cell carcinoma. | Aging (Albany NY) | 2022 | 36445337 | PubTator, text mining | PubMed |
| Genomic changes in Kaposi Sarcoma-associated Herpesvirus and their clinical correlates. | PLoS Pathog | 2022 | 36441790 | PubTator, text mining | PubMed |
| Identification and validation of a potential key gene SGOL1 for poor prognosis in hepatocellular carcinoma based on a bioinformatics approach. | Front Oncol | 2022 | 36439418 | PubTator, text mining | PubMed |
| Resolution of otitis media in a humanized mouse model. | Front Genet | 2022 | 36437913 | PubTator, text mining | PubMed |
| Immune phenotypes that are associated with subsequent COVID-19 severity inferred from post-recovery samples. | Nat Commun | 2022 | 36433939 | PubTator, text mining | PubMed |
| How the Tumor Micromilieu Modulates the Recruitment and Activation of Colorectal Cancer-Infiltrating Lymphocytes. | Biomedicines | 2022 | 36428508 | PubTator, text mining | PubMed |
| CD4+CD25+ T regulatory cells in renal transplantation. | Front Immunol | 2022 | 36426347 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1237/papers?page=23